Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
Identifieur interne : 005295 ( PubMed/Corpus ); précédent : 005294; suivant : 005296Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
Auteurs : P C Fan ; H W Peng ; C C ChenSource :
- The Journal of tropical medicine and hygiene [ 0022-5304 ] ; 1995.
English descriptors
- KwdEn :
- Acute Disease, Adult, Aged, Aged, 80 and over, Animals, Carrier State (drug therapy), Carrier State (epidemiology), Chronic Disease, Data Collection, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (therapeutic use), Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (etiology), Female, Filaricides (administration & dosage), Filaricides (therapeutic use), Follow-Up Studies, Humans, Male, Middle Aged, Sodium Chloride (administration & dosage), Sodium Chloride (therapeutic use), Taiwan (epidemiology), Wuchereria bancrofti.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides, Sodium Chloride.
- geographic , epidemiology : Taiwan.
- drug therapy : Carrier State, Elephantiasis, Filarial.
- epidemiology : Carrier State, Elephantiasis, Filarial.
- etiology : Elephantiasis, Filarial.
- chemical , therapeutic use : Diethylcarbamazine, Filaricides, Sodium Chloride.
- Acute Disease, Adult, Aged, Aged, 80 and over, Animals, Chronic Disease, Data Collection, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Wuchereria bancrofti.
Abstract
From May to December 1993, a house-by-house survey was conducted on the changes in clinical manifestations of filariasis among 814 pre-control mf carriers in 88 villages of five towns/districts on Kinmen Islands. Four hundred and sixteen (51%) pre-control mf carriers were examined physically with history taking. The rates of disappearance, improvement, no change, aggravation, and new occurrence were 72% (229), 6% (26), 14% (59), 6% (24) and 2% (8), respectively. The rates of disappearance and improvement were higher for the acute than for the chronic manifestations. However, these rates were also high for hydrocele and chyluria. These findings indicate that the acute manifestations disappear or greatly improve after filariasis eradication by a low dose of DEC medicated salt for a period of 6 months. However, the chronic ones remain unchanged or even aggravated to become one of the more important public health problems.
PubMed: 8544232
Links to Exploration step
pubmed:8544232Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.</title><author><name sortKey="Fan, P C" sort="Fan, P C" uniqKey="Fan P" first="P C" last="Fan">P C Fan</name><affiliation><nlm:affiliation>Department of Parasitology, School of Medicine, National Yangming University, Taipei, Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Peng, H W" sort="Peng, H W" uniqKey="Peng H" first="H W" last="Peng">H W Peng</name></author><author><name sortKey="Chen, C C" sort="Chen, C C" uniqKey="Chen C" first="C C" last="Chen">C C Chen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:8544232</idno><idno type="pmid">8544232</idno><idno type="wicri:Area/PubMed/Corpus">005295</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005295</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.</title><author><name sortKey="Fan, P C" sort="Fan, P C" uniqKey="Fan P" first="P C" last="Fan">P C Fan</name><affiliation><nlm:affiliation>Department of Parasitology, School of Medicine, National Yangming University, Taipei, Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Peng, H W" sort="Peng, H W" uniqKey="Peng H" first="H W" last="Peng">H W Peng</name></author><author><name sortKey="Chen, C C" sort="Chen, C C" uniqKey="Chen C" first="C C" last="Chen">C C Chen</name></author></analytic><series><title level="j">The Journal of tropical medicine and hygiene</title><idno type="ISSN">0022-5304</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Carrier State (drug therapy)</term><term>Carrier State (epidemiology)</term><term>Chronic Disease</term><term>Data Collection</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (etiology)</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Sodium Chloride (administration & dosage)</term><term>Sodium Chloride (therapeutic use)</term><term>Taiwan (epidemiology)</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Sodium Chloride</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Taiwan</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carrier State</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carrier State</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term><term>Sodium Chloride</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Chronic Disease</term><term>Data Collection</term><term>Drug Therapy, Combination</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Wuchereria bancrofti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">From May to December 1993, a house-by-house survey was conducted on the changes in clinical manifestations of filariasis among 814 pre-control mf carriers in 88 villages of five towns/districts on Kinmen Islands. Four hundred and sixteen (51%) pre-control mf carriers were examined physically with history taking. The rates of disappearance, improvement, no change, aggravation, and new occurrence were 72% (229), 6% (26), 14% (59), 6% (24) and 2% (8), respectively. The rates of disappearance and improvement were higher for the acute than for the chronic manifestations. However, these rates were also high for hydrocele and chyluria. These findings indicate that the acute manifestations disappear or greatly improve after filariasis eradication by a low dose of DEC medicated salt for a period of 6 months. However, the chronic ones remain unchanged or even aggravated to become one of the more important public health problems.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8544232</PMID><DateCreated><Year>1996</Year><Month>02</Month><Day>12</Day></DateCreated><DateCompleted><Year>1996</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-5304</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>6</Issue><PubDate><Year>1995</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of tropical medicine and hygiene</Title><ISOAbbreviation>J Trop Med Hyg</ISOAbbreviation></Journal><ArticleTitle>Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.</ArticleTitle><Pagination><MedlinePgn>461-4</MedlinePgn></Pagination><Abstract><AbstractText>From May to December 1993, a house-by-house survey was conducted on the changes in clinical manifestations of filariasis among 814 pre-control mf carriers in 88 villages of five towns/districts on Kinmen Islands. Four hundred and sixteen (51%) pre-control mf carriers were examined physically with history taking. The rates of disappearance, improvement, no change, aggravation, and new occurrence were 72% (229), 6% (26), 14% (59), 6% (24) and 2% (8), respectively. The rates of disappearance and improvement were higher for the acute than for the chronic manifestations. However, these rates were also high for hydrocele and chyluria. These findings indicate that the acute manifestations disappear or greatly improve after filariasis eradication by a low dose of DEC medicated salt for a period of 6 months. However, the chronic ones remain unchanged or even aggravated to become one of the more important public health problems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>P C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Parasitology, School of Medicine, National Yangming University, Taipei, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Trop Med Hyg</MedlineTA><NlmUniqueID>0406044</NlmUniqueID><ISSNLinking>0022-5304</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>451W47IQ8X</RegistryNumber><NameOfSubstance UI="D012965">Sodium Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002353" MajorTopicYN="N">Carrier State</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012965" MajorTopicYN="N">Sodium Chloride</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8544232</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005295 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 005295 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:8544232
|texte= Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:8544232" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |